Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage
Germany is considering an export ban on Novo Nordisk A/S’s blockbuster weight-loss drugs as European countries try to
2023-11-15 18:54
Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial
Novo Nordisk A/S gained another $14.5 billion of market value after a key study backed the use of
2023-11-13 20:54
Astra Enters Obesity Drug Race With Chinese Biotech Deal
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines, agreeing
2023-11-09 18:49
Sanofi Probed for Market Manipulation by French Authorities
French financial prosecutors are investigating Sanofi for alleged market manipulation. The preliminary probe opened in March involves alleged
2023-11-07 19:30
Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal
Roche Holding AG shares dropped after a trial of its gene therapy for Duchenne muscular dystrophy did not
2023-10-31 16:58
Novartis Lifts Outlook After Shedding Sandoz Generics
Novartis AG raised its profit forecast for a third time in the drugmaker’s first report after spinning off
2023-10-24 15:58
Sanofi to Explore Acquisition of Cancer Drugmaker Mirati
French pharmaceutical giant Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people
2023-10-06 03:27
Supreme Court Asked by Biden DOJ to Uphold Abortion-Pill Access
The Biden administration asked the US Supreme Court to uphold broad access to a widely used abortion pill,
2023-09-09 07:22
Ozempic Could Be The Next Target of Medicare Price Negotiations
Ozempic, Novo Nordisk A/S’s popular diabetes drug that’s also used for weight loss, could be one of the
2023-08-30 01:52
US Approves Ipsen’s Therapy for Rare Bone Disease
Ipsen SA’s drug for a debilitating disorder that slowly immobilizes patients within a cage of abnormal bone growth
2023-08-17 15:51
Pig Kidney Transplanted Into Human Shows Way to Wider Use
Doctors transplanted a pig’s kidney into a brain-dead man’s body where it continued to function normally, moving the
2023-08-16 23:53
Sanofi Was Mystery Bidder That Lost Reata to Biogen
Biogen Inc. narrowly beat out Sanofi SA to clinch its $7.3 billion acquisition of Reata Pharmaceuticals, according to
2023-08-16 03:45